Use of Ctdna in Patients With Gastrointestinal Tract Tumors

Recruiting Observational Study
Pancreas Cancer Colon Cancer Biliary Tract Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \>18 years * PS ECOG \<2; * Histological diagnosis of gastrointestinal cancer: esophageal, gastric, intestinal, pancreatic, biliary tract neoplasms; * Radiological evidence of resectable/locally advanced/metastatic disease on the date of signing the written informed consen…
Contacts

Lisa Salvatore, MD, PhD

+390630156318

lisa.salvatore@policlinicogemelli.it

CONTACT

Giovanni Trovato, MD

+390630156318

giovanni.trovato@guest.policlinicogemelli.it

CONTACT